Title

A Stepwise Strategy Utilizing Buprenorphine and Methadone
Graded Strategy for Pharmacological Treatment of Heroin Dependence
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    buprenorphine methadone ...
  • Study Participants

    96
The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy, where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient.
The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy (STEP), where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient.

For this purpose, 96 subjects at two centers (Uppsala and Stockholm) are randomized to MMT or STEP and followed for 6 months. Retention in treatment is the primary outcome. Secondary outcomes in completers are proportion urine samples free of illicit opiates on app. twice weekly sampling, and problem severity as measured by a semistructured interview, the Addiction Severity Index (ASI) at baseline and after 3 and 6 months.
Study Started
Aug 31
2005
Study Completion
Mar 31
2006
Last Update
Oct 24
2006
Estimate

Drug methadone

Drug buprenorphine / methadone sequence

Behavioral Relapse prevention

Behavioral Contingency management

Criteria

Inclusion Criteria:

Heroin dependence according to DSM IV > 1year
Age > 20 years
Acceptance of the stated treatment principles.

Exclusion Criteria:

Severe psychiatric illness such as dementia or psychosis compromising the patient's ability to provide informed consent
Other clinically significant psychiatric illness unless stable under treatment
Severe medical condition such as advanced lung disease, unstable cardiovascular disease, severe liver disease
Other clinically significant medical condition unless stable under treatment
Treatment with anti-seizure drugs or disulfiram
Pregnancy or intent to become pregnant within the next year
Ongoing nursing
Patients involuntarily discharged from a methadone or buprenorphine maintenance program within the last 3 months not eligible.
No Results Posted